Xeleris V*

Xeleris V, a virtual processing and review solution for nuclear medicine that removes the restraints of a dedicated station.

Dedicated processing and review stations have long been integral to nuclear medicine and they come with certain challenges. Fixed workstations are restrictive. You need better access and availability from different locations inside and outside the hospital. Additionally, individual purchases across your workstations made over time could result in variabilities that raise costs and slow down your productivity.

With Xeleris^TM V, GE Healthcare’s new virtual processing and review solution for nuclear medicine, we have removed the restraints of a dedicated processing and review station. Together with Smart Subscription and advanced AI applications powered by Edison^TM, we are transforming the way nuclear medicine works. Xeleris V is mobile, scalable, accessible, intelligent and always up to date. You can upgrade by purchasing Xeleris V outright or by acquiring it with Smart Subscription, our cutting-edge subscription service that keeps your systems synchronized to each other and to the latest software.

We realize you continue to be pushed to do even more with less time. You need new ways to reach quick, confident results. Xeleris V provides greater mobility, flexibility and access by removing the limitations of a dedicated nuclear medicine workstation. Now you can go wherever your work takes you and still have powerful clinical insight close at hand.

Dedicated processing and review workstations put a strain on your workflow and budget. Varying access and availability within hospitals, along with the fixed nature of workstations, increase the time it takes you to reach a diagnosis. Moreover, purchases made over time result in varying capabilities within your facility’s workstations, requiring extra technologist training, IT support and maintenance. We created a thin-client, scalable solution with Xeleris V. Now you can work with your nuclear medicine data from anywhere in a virtualized environment. In addition to greater mobility, the architecture of Xeleris V provides a high level of security and data accessibility by bringing all of your imaging data together in the cloud.

Xeleris V cuts the ties from your nuclear medicine applications to any specific hardware. Using the software-as-a-solution model, Xeleris V provides unrestricted access to applications, creating a virtual environment where you can easily scale Xeleris V from three to five to 10 concurrent users.

Application variations within a fleet of workstations increase costs and cause complications for your staff. We saw an opportunity for innovation. As always, you have the choice to purchase your applications outright. Now you can choose to opt-in to Smart Subscription, our new subscription-based service. Smart Subscription is designed to keep all of your systems up to date, so you don’t have to update them yourself.

The industry-wide trend toward precision care is raising the standard of healthcare. It’s also raising the standard on radiologists, adding pressure to create even more accurate, productive and reproducible results. This increased need for accuracy in turn increases the complexity of manual workflows like organ segmentation and dose calculations. Xeleris V makes it easy to efficiently and accurately complete organ segmentation in order to help meet the standard of precision care.

Powered by Edison

Edison is GE’s intelligence platform, designed to help you achieve greater efficiency, improve patient outcomes and increase access to care. You can securely deploy Edison to your nuclear medicine workstations via the cloud, Edison HealthLink or direct upload. Edison-enabled devices can integrate and assimilate data from disparate sources and apply analytics or advanced algorithms to generate clinical, operational and financial insights.

It knows its way around anatomy. Automatically.

Xeleris V AI-enabled clinical applications provide an accurate, efficient and reproducible way to segment organs. With automatic deep learning-based applications, Xeleris V can automatically segment lung lobes for preoperative functional assessment of lung cancer cases. It can also automatically segment the lungs and trachea for evaluation of pulmonary embolism cases. This AI-enabled lung segmentation demonstrated an overall success rate of 89 percent¹ and reduction in the number of clicks by an average of 57 percent².

A well-calculated plan

AI-enabled clinical applications have the potential to greatly improve efficiency and precision in nuclear oncology. Xeleris V leverages AI to accurately segment organs for quantitation and dosimetry calculations. Q.Thera AI* is designed to reduce by more than 55% the time required for the user to process and calculate dose.

*Not for sale. Not cleared or approved by the U.S. FDA.

The base collection of applications installed on Xeleris V provide the essential processing and review capabilities for nuclear medicine. We also offer additional application packages based on common imaging categories so you can easily pick the packages that meet your healthcare system’s needs. And with Smart Subscription, these application packages will evolve with our regular application rollout schedule.

• Evolution for Bone SPECT, Planar Bone, Cardiac & Tool Kit
  
  
• Volumetrix MI with CT/MR Image Reconstruction & External or Single CTAC
  
  
• Myovation, First Pass, EF Analysis, Peak Filling Rate & L-R Shunt
  
  
• SPECT & Dynamic Motion Detection & Correction
  
  
• WB Bone & Spots Review
  
  
• Lung Analysis
  
  
• Renal Analysis, Manchester & DMSA Renogram
  
  
• Gallbladder EF, Gastric Emptying, Esophageal Motility 
  
  
• Brain SPECT 
  
  
• Thyroid Uptake & Parathyroid Imaging Analysis 
  
  
• Workspace/Launch Two/Dual Monitor Support 
  
  
• User Commands & Aladdin TM /Anonymized Export

Advanced Reconstruction Package

The Advanced Reconstruction Package offers the latest advanced reconstruction tools for CZT-based SPECT/CT and multi-vendor SPECT or PET/CT registration.

• Multi-vendor CT Image Registration

• General Purpose CZT-based SPECT/CT Tool Kit ³

Quantitation Package

The quantitation package takes your MI practice to the next level with applications for the concurrent review and quantitative assessment of general SPECT/CT or more specialized processing and evaluation of lung SPECT/CT.

Cardiology Reconstruction Package

The cardiology package provides increased capabilities with advanced 3D motion correction and reconstruction tools for CZT-based cardiac SPECT, externally acquired CT attenuation correction and cardiac innervation image processing.

• External, Single & Multi-Vendor CT Attenuation Correction
  
  
• Adreview Planar & Cardiac Morphing

• Alcyone Basic, Advanced & Motion Management ⁴

Neurology Package

The neurology package includes a number of useful applications for functional brain imaging, including protocols for automatic reconstruction and reformatting, 3D rendering and a motion correction algorithm. With Q.Brain, you can assess and quantify pathologies derived from brain SPECT and PET scans. And DaTQUANT^TM assists in detecting the loss of functional dopaminergic neuron terminals in the striatum, which can help diagnose Parkinson’s disease.

• DaTQUANT (includes DaTQUANT Normals)

• Q.Brain (includes HMPAO, ECD, IMP & FDG Databases)

Dosimetry Package

The Dosimetry package provides for multi-organ planar and 3D PET/CT or SPECT/CT dosimetry and more specialized dosimetry for SIRT planning.

In order to bring even more innovative clinical applications to Xeleris V, we partnered with the experts in third-party software. We collaborated closely to ensure these third-party applications will seamlessly integrate with the Xeleris V platform and billing.

The EXINI® Bone application provides displays of the available anterior and posterior whole-body bone scan images, segmentation of skeletal regions, highlights of hotspots with locally increased uptake, calculations of the bone scan index from these hotspots and the option to display and analyze multiple studies simultaneously. The application incorporates AI to execute these functions.

The EXINI Bone application gives a fully quantitative assessment of bone scans that incorporates inferred masses of all lesions. The computed index reflects the proportion of the total skeleton mass that is observed to have tumor involvement.

The traditional “buy, use, replace” acquisition model makes it difficult to stay up to date with the latest molecular imaging trends. Xeleris V, together with Smart Subscription, takes the work out of your hands by adding all of your applications to the cloud and keeping them up to date.

Xeleris V is the virtual processing and review solution that delivers the efficiency and accuracy you’ve been waiting for. With Xeleris V, we have built a modality that will transform the way nuclear medicine works for enterprise imaging by eliminating standalone workstations and bringing all of your applications to a centralized, virtual location your team can access across your entire network.

There are two ways to acquire Xeleris V and keep it current. You can purchase Xeleris V outright and choose the right applications for your system, or you can purchase Xeleris V with Smart Subscription. The combination of Xeleris V with Smart Subscription and advanced AI applications powered by Edison are making nuclear medicine more mobile, scalable, accessible, intelligent and up to date than ever before. Speak with a sales representative to learn more about how Xeleris V can evolve your nuclear medicine systems.

Images are for illustration purposes only. See Xeleris V minimum requirements for supported client devices.

Quantitative Perfusion SPECT, Quantitative Gated SPECT, Quantitative Blood Pool GSPECT and Automatic Report Generator are trademarks of Cedars Sinai.

Emory Toolbox, Emory SyncTools, Emory SmartReport and Emory PETtools are trademarks of Syntermed Medical Imaging.

ASNC ImageGuide is a trademark of the American Society of Nuclear Cardiology.

Xeleris, Edison and Discovery are trademarks of GE.

¹As demonstrated in an evaluation consisting of 99 SPECT/CT cases and three physicians, where each case was segmented manually and using the AI-based algorithm and evaluated by one of the physicians. In 89 of the cases, the AI-based segmentation met the success criteria of (a) less than three manual edits, and (b) lobe volume and activity within a predefined threshold compared to manual segmentation.

²Compared to Q.Lung on Xeleris 4 DR. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow for pulmonary embolism diagnosis and lung function assessment. Results may vary.

³Applicable for SPECT from Discovery NM/CT 670 CZT and NM/CT 870 CZT.

⁴Applicable for Discovery NM/CT 530c and Discovery NM/CT 570c.

⁵Compared to using Xeleris 4 DR Q.Volumetrix MI. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.

⁶Compared to using Xeleris 4 DR Q.Volumetrix MI with manual or external software dose calculation. As demonstrated in an evaluation at two sites consisting of 15 SPECT/CT cases and two physicians, where each case was processed by one of the two physicians. Results may vary.

⁷Compared to using Xeleris 4 DR Q.Volumetrix with manual or external software dose calculation. As demonstrated in bench test using five SPECT/CT cases. The bench test covered the workflow from data loading to dose calculation using user pre-defined formulas. Results may vary.